INFORME DE UTILIDADE PÚBLICA PARA PORTADORES DE DIABETES!
A mensagem abaixo é um texto de publicidade, que multiplicamos dada a importância do assunto para portadores de Diabetes Mellitus, que precisam de realizar monitoração e aplicações diárias de insulina, como o nosso filho, Samuel.
Com a CANETA SAFE-INJECT PARA APLICAÇÃO DE INSULINA SEM AGULHA o desconforto e a ansiedade relacionados ao momento da picada da agulha são coisas do passado.
Em uma fração de segundos a CANETA SAFE-INJECT PARA APLICAÇÃO DE INSULINA SEM AGULHA, introduz qualquer tipo de insulina de forma segura. Por utilizar mecanismo de pressão, a CANETA SAFE-INJECT preserva o tecido e evita lesões e infecções que comumente ocorrem em decorrência do uso de agulhas. Ainda é possível realizar a combinação de insulinas na mesma aplicação.
Produzina na Alemanha, a CANETA SAFE-INJECT PARA APLICAÇÃO DE INSULINA SEM AGULHA já é amplamente utilizada em vários outros países. Possui selo de qualidade ISO, registro CE (Comunidade Européia) e muitos trabalhos científicos que comprovam sua eficácia e segurança.
A CANETA SAFE-INJECT PARA APLICAÇÃO DE INSULINA SEM AGULHA já está registrada na ANVISA e será comercializada a partir de agosto de 2011 no Brasil pela Hemocat, empresa que atua há mais de 20 anos na área de saúde. O valor estimado do kit inicial completo – 1 caneta Safe-Inject, reset Box, 4 adaptadores para frasco-ampola de insulina, 10 ampolas Safe-Inject, manual impresso, cd explicativo e bolsa – será de R$ 1.200,00. O consumo de descartáveis – ampolas e adaptadores – deve girar em torno de R$ 100,00 a R$ 300,00 mensais, de acordo com a rotina de utilização de insulina do usuário.
A Hemocat fará o lançamento oficial da CANETA SAFE-INJECT PARA APLICAÇÃO DE INSULINA SEM AGULHA no 16º Congresso Brasileiro Multidisciplinar em Diabetes, de 29 a 31 de julho de 2011 em São Paulo, organizado pela ANAD – Associação Nacional de Assistência ao Diabético.
Fonte da informação: Hemocat Comércio e Importação Ltda. http://www.hemocat.com.br/
Gerente de Marketing: Danila Castro (danila@hemocat.com.br)
-----
Translate (http://translate.google.com.br/)
REPORT OF PUBLIC UTILITY FOR PEOPLE WITH DIABETES!
The message below is a text advertising, multiply given the importance of the issue for people with diabetes mellitus, they need to perform monitoring and daily insulin applications, as our son, Samuel.
The message below is a text advertising, multiply given the importance of the issue for people with diabetes mellitus, they need to perform monitoring and daily insulin applications, as our son, Samuel.
We are candidates to buy the pen, once it becomes commercially available.
The availability of similar products is subject to import (U.S., Britain, Holland, Germany, etc.), and with the uncertainty of efficacy, support staff in Portuguese and maintenance costs (inputs).
In our contact with the company Hemocat, we received the report below, which replenished. If you are interested, or know someone who needs the information, please pass.
Joserrí de Oliveira Lucena
With SAFE-PEN APPLICATION TO INJECT INSULIN WITHOUT NEEDLE discomfort and anxiety related to the time of needle stick are over.
In a split second a INJECT-SAFE PEN FOR THE APPLICATION OF INSULIN WITHOUT NEEDLE, introduce any type of insulin safely. By using pressure mechanism, the SAFE-INJECT PEN preserves the tissue and prevents injuries and infections that commonly occur due to the use of needles. It is still possible to make the combination of insulin in the same application.
Pouring alloys in Germany, the PEN TO INJECT-SAFE USE OF INSULIN WITHOUT NEEDLE is already widely used in several other countries. It has ISO seal of approval, registration EC (European Community) and many scientific studies that prove its efficacy and safety.
PEN TO INJECT-SAFE USE OF INSULIN WITHOUT NEEDLE already registered and will be marketed in ANVISA from August 2011 in Brazil by Hemocat, a company operating for over 20 years in healthcare. The estimated value of the complete starter kit - a pen-Safe Inject, reset Box, 4 adapters for insulin vials, ampoules 10 Inject-Safe, manual, cd explanatory and purse - will be R$ 1,200.00. The consumption of disposable - light bulbs and fittings - should be around R$ 100.00 to R$ 300.00 a month, according to the routine use of insulin for the user.
The Hemocat will officially launch the SAFE-INJECT PEN FOR THE APPLICATION OF INSULIN NEEDLE WITHOUT the 16th Brazilian Congress Multidisciplinary Diabetes, 29 to 31 July 2011 in São Paulo, organized by ANAD - National Association of Diabetes Care.
Source of information: Hemocat Comércio e Importação Ltda. http://www.hemocat.com.br/
In our contact with the company Hemocat, we received the report below, which replenished. If you are interested, or know someone who needs the information, please pass.
Joserrí de Oliveira Lucena
With SAFE-PEN APPLICATION TO INJECT INSULIN WITHOUT NEEDLE discomfort and anxiety related to the time of needle stick are over.
In a split second a INJECT-SAFE PEN FOR THE APPLICATION OF INSULIN WITHOUT NEEDLE, introduce any type of insulin safely. By using pressure mechanism, the SAFE-INJECT PEN preserves the tissue and prevents injuries and infections that commonly occur due to the use of needles. It is still possible to make the combination of insulin in the same application.
Pouring alloys in Germany, the PEN TO INJECT-SAFE USE OF INSULIN WITHOUT NEEDLE is already widely used in several other countries. It has ISO seal of approval, registration EC (European Community) and many scientific studies that prove its efficacy and safety.
PEN TO INJECT-SAFE USE OF INSULIN WITHOUT NEEDLE already registered and will be marketed in ANVISA from August 2011 in Brazil by Hemocat, a company operating for over 20 years in healthcare. The estimated value of the complete starter kit - a pen-Safe Inject, reset Box, 4 adapters for insulin vials, ampoules 10 Inject-Safe, manual, cd explanatory and purse - will be R$ 1,200.00. The consumption of disposable - light bulbs and fittings - should be around R$ 100.00 to R$ 300.00 a month, according to the routine use of insulin for the user.
The Hemocat will officially launch the SAFE-INJECT PEN FOR THE APPLICATION OF INSULIN NEEDLE WITHOUT the 16th Brazilian Congress Multidisciplinary Diabetes, 29 to 31 July 2011 in São Paulo, organized by ANAD - National Association of Diabetes Care.
Source of information: Hemocat Comércio e Importação Ltda. http://www.hemocat.com.br/
Marketing Manager: Danila Castro (danila@hemocat.com.br)